Inflammation-targeted nanomedicine against brain cancer: From design strategies to future developments.
- DOI
- 10.1016/j.semcancer.2022.08.007
- Published
- 2022 Nov
- Container
- Seminars in cancer biology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.semcancer.2022.08.007,
title = {Inflammation-targeted nanomedicine against brain cancer: From design strategies to future developments.},
author = {Mamun AA and Uddin MS and Perveen A and Jha NK and Alghamdi BS and Jeandet P and Zhang HJ and Ashraf GM},
year = {2022},
journal = {Seminars in cancer biology},
doi = {10.1016/j.semcancer.2022.08.007},
url = {https://doi.org/10.1016/j.semcancer.2022.08.007}
}RIS
TY - JOUR TI - Inflammation-targeted nanomedicine against brain cancer: From design strategies to future developments. AU - Mamun AA AU - Uddin MS AU - Perveen A AU - Jha NK AU - Alghamdi BS AU - Jeandet P AU - Zhang HJ AU - Ashraf GM PY - 2022 JO - Seminars in cancer biology DO - 10.1016/j.semcancer.2022.08.007 UR - https://doi.org/10.1016/j.semcancer.2022.08.007 ER -
APA
AA, M., MS, U., A, P., NK, J., BS, A., P, J., HJ, Z., & GM, A. (2022). Inflammation-targeted nanomedicine against brain cancer: From design strategies to future developments.. Seminars in cancer biology. https://doi.org/10.1016/j.semcancer.2022.08.007
Source records
- pubmed · retrieved 2026-09-25T15:31:13.604Z